Education
About Us
Working with TipRanks
Follow Us
Medline (MDLN)
NASDAQ:MDLN
MDLN Stock Chart & Stats
$44.55
--
Market closed
$44.55
--
Day’s Range― - ―
52-Week Range$34.89 - $50.88
Previous CloseN/A
VolumeN/A
Average Volume (3M)8.56M
Market Cap
$62.41B
Enterprise Value$47.83B
Total Cash (Recent Filing)$1.94B
Total Debt (Recent Filing)$12.56B
Price to Earnings (P/E)32.9
Beta3.40
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding811,647,500
10 Day Avg. Volume1,994,195
30 Day Avg. Volume8,556,617
Financial Highlights & Ratios
PEG Ratio-4.97
Price to Book (P/B)3.18
Price to Sales (P/S)1.20
P/FCF Ratio19.56
Enterprise Value/Market Cap0.77
Enterprise Value/Revenue1.68
Enterprise Value/Gross Profit6.84
Enterprise Value/Ebitda15.39
Forecast
1Y Price Target
$52.04Price Target Upside16.81% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering27
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diversified Manufacturing & Distribution ModelIntegrated manufacturing plus third-party distribution creates durable revenue diversification and high customer stickiness. Long-term hospital contracts, GPO participation and logistics services drive recurring orders, scale purchasing advantages and margin resilience across care settings.
Revenue Scaling And Improving Gross MarginsSustained top-line expansion alongside rising gross margins suggests durable improvements in pricing, product mix or cost control. This supports ongoing cash generation and reinvestment capacity, making growth more self-funding and strengthening competitive position over the medium term.
IPO Proceeds Used To Reduce Debt; Governance UpgradesProceeds-driven deleveraging materially reduces refinancing risk and interest burden, while new governance and incentive structures improve alignment with public investors. Together these steps increase strategic flexibility for capital allocation and long-term stability.
Bears Say
Meaningful Leverage RemainsA debt-to-equity ratio near or above 1x leaves limited balance sheet flexibility and raises sensitivity to slower demand or margin pressure. High leverage can constrain investment, increase interest expense risk, and reduce the company’s ability to absorb shocks over the medium term.
Margin Volatility And Weak Net Margin ConversionInconsistent operating leverage means revenue growth doesn't reliably translate into higher net profits. Persistent margin volatility reduces earnings predictability, complicates planning for reinvestment or deleveraging, and can undermine long-term return expectations.
Earnings-to-cash Quality InconsistencyWhen cash generation lags reported earnings, underlying profitability may be weaker than accruals suggest. Reliance on working-capital for growth can tighten liquidity and force incremental financing, elevating operational risk during cyclical downturns or rapid expansion phases.
Medline News
MDLN FAQ
What was Medline’s price range in the past 12 months?
Medline lowest stock price was $34.89 and its highest was $50.88 in the past 12 months.
What is Medline’s market cap?
Medline’s market cap is $62.41B.
When is Medline’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Medline’s earnings last quarter?
Currently, no data Available
Is Medline overvalued?
According to Wall Street analysts Medline’s price is currently Undervalued.
Does Medline pay dividends?
Medline does not currently pay dividends.
What is Medline’s EPS estimate?
Medline’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medline have?
Medline has 811,647,500 shares outstanding.
What happened to Medline’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Medline?
Currently, no hedge funds are holding shares in MDLN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Medline Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$52.04 (16.81% Upside)
$52.04 (16.81% Upside)
Blogger Sentiment
Bullish
MDLN Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth $2.0B over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 2.7%
Last 30 Days ▼ 2.7%
News Sentiment
Very Bullish
Bullish news 97%
Bearish news 3%
Bearish news 3%
Company Description
Medline
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services such as, consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. Medline Inc. was founded in 1966 and is based in Northfield, Illinois.
MDLN Earnings Call
Q4 2026
0:00 / 0:00
MDLN Stock 12 Month Forecast
Average Price Target
$52.04
▲(16.81% Upside)
Baxter International
―
Becton Dickinson
―
ICU Medical
―
Merit Medical Systems
―
Teleflex
―